Clinical and virological effects of NA inhibitors in pediatric patients with influenza B virus infection (between 4 years and 12 years old):an open-label,randomized study.

Next Previous
Trial Profile

Clinical and virological effects of NA inhibitors in pediatric patients with influenza B virus infection (between 4 years and 12 years old):an open-label,randomized study.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 31 May 2016

At a glance

  • Drugs Oseltamivir (Primary) ; Peramivir (Primary)
  • Indications Influenza B virus infections
  • Focus Therapeutic Use

    • Most Recent Events

    • 31 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top